Intra-Cellular Therapies Inc (ITCI)

Track

Stock chart
Ticker: ITCI Exchange: NSM


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Earnings
 
Value bought

Past 90 days

 
Value sold

Past 90 days

 
Net insiders buying

Past 90 days

 
Trades (buy and sell)

Past 90 days

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-06 2024-12-05 PS Planned sale

Mates Sharon

Chairman and CEO

Executive Director
1,534 -0.1%
84.69
USD 129,914 		1,534 -0.1% 84.69 USD 129,914
2024-12-06 2024-12-05 PS Planned sale

Mates Sharon

Chairman and CEO

Executive Director
50,163 -4.5%
84.06
USD 4,216,928 		50,163 -4.5% 84.06 USD 4,216,928
2024-12-06 2024-12-04 PS Planned sale

Mates Sharon

Chairman and CEO

Executive Director
23,333 -2.1%
86.00
USD 2,006,750 		23,333 -2.1% 86.00 USD 2,006,750
2024-12-06 2024-12-04 PS Planned sale

Mates Sharon

Chairman and CEO

Executive Director
27,667 -2.5%
85.62
USD 2,368,909 		27,667 -2.5% 85.62 USD 2,368,909
2024-11-14 2024-11-13 PS Planned sale

Halstead Michael

President

Officer
5,343 -100.0%
88.92
USD 475,100 		5,343 -100.0% 88.92 USD 475,100
2024-11-14 2024-11-13 PS Planned sale

Halstead Michael

President

Officer
13,371 -71.4%
88.17
USD 1,178,921 		13,371 -71.4% 88.17 USD 1,178,921
2024-11-14 2024-11-12 PS Planned sale

Halstead Michael

President

Officer
1,648 -100.0%
90.89
USD 149,787 		1,648 -100.0% 90.89 USD 149,787
2024-11-14 2024-11-12 PS Planned sale

Halstead Michael

President

Officer
6,116 -78.8%
89.63
USD 548,177 		6,116 -78.8% 89.63 USD 548,177
2024-11-14 2024-11-12 PS Planned sale

Halstead Michael

President

Officer
15,105 -66.1%
88.72
USD 1,340,116 		15,105 -66.1% 88.72 USD 1,340,116
2024-08-30 2024-08-30 PS Planned sale

Mates Sharon

Chairman and CEO

Executive Director
6,193 -0.6%
73.32
USD 454,091 		6,193 -0.6% 73.32 USD 454,091
2024-08-30 2024-08-30 PS Planned sale

Mates Sharon

Chairman and CEO

Executive Director
28,203 -2.6%
72.73
USD 2,051,261 		28,203 -2.6% 72.73 USD 2,051,261
2024-08-30 2024-08-29 PS Planned sale

Mates Sharon

Chairman and CEO

Executive Director
5,772 -0.5%
73.25
USD 422,771 		5,772 -0.5% 73.25 USD 422,771
2024-08-30 2024-08-29 PS Planned sale

Mates Sharon

Chairman and CEO

Executive Director
29,832 -2.7%
72.44
USD 2,161,114 		29,832 -2.7% 72.44 USD 2,161,114
2024-08-28 2024-08-28 PS Planned sale

Mates Sharon

Chairman and CEO

Executive Director
240 -0.0%
73.70
USD 17,688 		240 -0.0% 73.70 USD 17,688
2024-08-28 2024-08-28 PS Planned sale

Mates Sharon

Chairman and CEO

Executive Director
240 -0.0%
73.70
USD 17,688 		240 -0.0% 73.70 USD 17,688
2024-08-28 2024-08-28 PS Planned sale

Mates Sharon

Chairman and CEO

Executive Director
32,459 -2.9%
72.74
USD 2,361,113 		32,459 -2.9% 72.74 USD 2,361,113
2024-08-28 2024-08-28 PS Planned sale

Mates Sharon

Chairman and CEO

Executive Director
32,459 -2.9%
72.74
USD 2,361,113 		32,459 -2.9% 72.74 USD 2,361,113
2024-08-28 2024-08-27 PS Planned sale

Mates Sharon

Chairman and CEO

Executive Director
16,856 -1.6%
73.93
USD 1,246,191 		16,856 -1.6% 73.93 USD 1,246,191
2024-08-28 2024-08-27 PS Planned sale

Mates Sharon

Chairman and CEO

Executive Director
16,856 -1.6%
73.93
USD 1,246,191 		16,856 -1.6% 73.93 USD 1,246,191
2024-08-28 2024-08-27 PS Planned sale

Mates Sharon

Chairman and CEO

Executive Director
23,657 -2.1%
73.33
USD 1,734,865 		23,657 -2.1% 73.33 USD 1,734,865
// ... existing code ...